Institutional Repository

Neuroleptic drug use in long-term care: An inappropriate panacea?

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Hagen, Brad F.
dc.contributor.author Armstrong-Esther, Christopher
dc.date.accessioned 2007-10-30T20:13:49Z
dc.date.available 2007-10-30T20:13:49Z
dc.date.issued 2001-06
dc.identifier.citation Hagen, B., & Armstrong-Esther, C. (2001). Neuroleptic drug use in long-term care: An inappropriate panacea? Quality in Ageing - Policy, Practice and Research, 2(2), 31-41. en
dc.identifier.issn 1471-7794
dc.identifier.uri http://hdl.handle.net/10133/520
dc.description.abstract Despite the increasing evidence about the inappropriate use of medications by older people, there is very little published evidence about the control and monitoring of neuroleptic drugs used in nursing homes. As others have indicated, this is all the more worrying when set in the context of the paucity of research on nursing home care and the trend to replace registered nurses with untrained care assistants. In the United States, legislation in the form of the Nursing Home Reform Act (OBRA 1987) was introduced, in part, to regulate the prescribing and administration of neuroleptic (antipsychotic) drugs. No such legislation exists in Canada or the United Kingdom. In the case of the latter jurisdiction, the recent Royal Commission on Long-Term Care for older people (The Stationery Office, 1999) has recommended a national care commission to monitor care, and set assessment and quality benchmarks. In Canada this debate has not even begun, and the purpose of this paper is not to ignite controversy, but to raise questions about the use of these drugs with nursing home residents. Voluntary guidelines and education of physicians, nurses and care attendants would be infinitely better than legislation. In the meantime, we need research to address the following questions: For what reasons should these drugs be given to older people? Are these drugs being used appropriately? Is the risk of side-effects too great with these drugs? Are the numbers and type of staff employed in nursing homes adequate/qualified to detect and report side-effects? How well do these drugs manage the behaviours they are given lo control? Are they being used as chemical restraints or to make the older person compliant? Are the so-called 'atypical' neuroleptic drugs any better? What we offer in this article is background information that might encourage others to not only review their practice but also to address these questions. en
dc.language.iso en en
dc.publisher Pavilion Publishing en
dc.subject Nursing home care en
dc.subject Older people -- Mental health en
dc.title Neuroleptic drug use in long-term care: An inappropriate panacea? en
dc.type Article en
dc.publisher.faculty School of Health Sciences en
dc.description.peer-review Yes en
dc.publisher.institution University of Lethbridge en

Files in this item

This item appears in the following Collection(s)

Show simple item record

Related Items

Search DSpace


Advanced Search

Browse

My Account

Statistics